Skip to content

AMEXDRUG CORP

company.status.inactive

CIK 45621fmd_0TZK18M8XC94Z7507NDZ6GSRZFWholesale Trade · Wholesale-Drugs, Proprietaries & Druggists' SundriesTemplate: Standard

Coverage: Jan 01, 2010 to Jun 30, 2013, 13 periods

Latest annual · FY2012

Millions
Total revenues
9
Gross profit
1
Operating income
0
Net income
0
Free cash flow
0

Latest quarter · Q2 FY2013

Millions
Total revenues
2
Gross profit
0
Operating income
0
Net income
0
Free cash flow
0
Open Financials

AMEXDRUG CORP financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2012FY2011ChangeSource
Revenue$9.1 million$12.4 million-26.3%10-K 2013-04-03 · proof
Gross profit$1 million$995,746+1.1%10-K 2013-04-03 · proof
Operating income$195,855$221,309-11.5%10-K 2013-04-03 · proof
Net income$82,034$100,647-18.5%10-K 2013-04-03 · proof
Cash from operating activities-$160,804-$137,01610-K 2013-04-03 · proof
Free cash flow$297,784-$94,56010-K 2013-04-03 · proof
Total assets$2.4 million$1.6 million+50.6%10-Q 2013-05-20 · proof
Total liabilities$2 million$1.2 million+58.2%10-K 2013-04-03 · proof
Cash and cash equivalents$415,962$589,472-29.4%10-K 2013-04-03 · proof
What was AMEXDRUG CORP's revenue in fiscal 2012?
AMEXDRUG CORP reported revenue of $9.1 million for fiscal 2012 (the year ended Dec 31, 2012), against $12.4 million the year before (-26.3%). Source: the 10-K filed with the SEC on Apr 3, 2013. SEC
What was AMEXDRUG CORP's gross profit in fiscal 2012?
AMEXDRUG CORP reported gross profit of $1 million for fiscal 2012 (the year ended Dec 31, 2012), against $995,746 the year before (+1.1%). Source: the 10-K filed with the SEC on Apr 3, 2013. SEC
What was AMEXDRUG CORP's operating income in fiscal 2012?
AMEXDRUG CORP reported operating income of $195,855 for fiscal 2012 (the year ended Dec 31, 2012), against $221,309 the year before (-11.5%). Source: the 10-K filed with the SEC on Apr 3, 2013. SEC
What was AMEXDRUG CORP's net income in fiscal 2012?
AMEXDRUG CORP reported net income of $82,034 for fiscal 2012 (the year ended Dec 31, 2012), against $100,647 the year before (-18.5%). Source: the 10-K filed with the SEC on Apr 3, 2013. SEC
What was AMEXDRUG CORP's cash from operating activities in fiscal 2012?
AMEXDRUG CORP reported cash from operating activities of -$160,804 for fiscal 2012 (the year ended Dec 31, 2012), against -$137,016 the year before. Source: the 10-K filed with the SEC on Apr 3, 2013. SEC
What was AMEXDRUG CORP's free cash flow in fiscal 2012?
AMEXDRUG CORP reported free cash flow of $297,784 for fiscal 2012 (the year ended Dec 31, 2012), against -$94,560 the year before. Source: the 10-K filed with the SEC on Apr 3, 2013. SEC
What are AMEXDRUG CORP's total assets?
As of Dec 31, 2012, AMEXDRUG CORP reported total assets of $2.4 million, against $1.6 million a year earlier (+50.6%). Source: the 10-Q filed with the SEC on May 20, 2013 (restated). SEC
What are AMEXDRUG CORP's total liabilities?
As of Dec 31, 2012, AMEXDRUG CORP reported total liabilities of $2 million, against $1.2 million a year earlier (+58.2%). Source: the 10-K filed with the SEC on Apr 3, 2013. SEC
What are AMEXDRUG CORP's cash and cash equivalents?
As of Dec 31, 2012, AMEXDRUG CORP reported cash and cash equivalents of $415,962, against $589,472 a year earlier (-29.4%). Source: the 10-K filed with the SEC on Apr 3, 2013. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:45621&period_type=annual&limit=5"

Information only, not investment advice.